Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Oxaliplatin for injection
Indication: It can be used alone or in combination with fluorouracil for patients with colorectal cancer metastasis who have failed treatment with fluorouracil.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical (Hainan) Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Qilu Pharmaceutical Co., Ltd.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Tegafur Injection
Indication: It is mainly used to treat digestive tract tumors, such as gastric cancer, colorectal cancer, pancreatic cancer, liver cancer, and can also be used for breast cancer.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
Xiao Cancer Tablets
Manufacturer:
Hubei Chuangli Pharmaceutical Co., Ltd.
Related Ingredients
-
Oxaliplatin list
61825-94-3 -
Tegafur list
17902-23-7 -
1,10-Phenanthroline hydrate list
5144-89-8